Development of an Enzyme-Linked Immunosorbent Assay (ELISA) for Accurate and Prompt Coronavirus Disease 2019 (COVID-19) Diagnosis Using the Rational Selection of Serological Biomarkers

Prompt COVID-19 diagnosis is urgently required to support infection control measures. Currently available serological tests for measuring SARS-CoV-2 antibodies use different target antigens, although their sensitivity and specificity presents a challenge. We aimed to develop an “in-house” serologica...

Descripción completa

Detalles Bibliográficos
Autores principales: Lagousi, Theano, Routsias, John, Spoulou, Vana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8618656/
https://www.ncbi.nlm.nih.gov/pubmed/34829317
http://dx.doi.org/10.3390/diagnostics11111970

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8618656/
https://www.ncbi.nlm.nih.gov/pubmed/34829317
http://dx.doi.org/10.3390/diagnostics11111970

Ejemplares similares